CSF and serum orosomucoid (α-1-acid glycoprotein) in patients with multiple sclerosis: a comparison among particular subgroups of MS patients
Authors:
- Pavel AdamPAPavel Adam
- Ondřej SobekOSOndřej Sobek
- Luděk TáborskýLTLuděk Táborský
- Thomas HildebrandTHThomas Hildebrand
- Olga TutterováOTOlga Tutterová
- Petr ŽáčekPŽPetr Žáček
- 1 August 2003
- journal article
- research article
- Published by Elsevier in Clinica Chimica Acta
- Vol. 334 (1-2) , 107-110
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Cerebrospinal fluid2001
- Cerebrospinal Fluid Cytologic Findings in Multiple SclerosisActa Cytologica, 2001
- Transferrin in patients with multiple sclerosis: a comparison among various subgroups of multiple sclerosis patientsActa Neurologica Scandinavica, 2000
- Comparison of concentration of orosomucoid in serum and cerebrospinal fluid in different neurological diseasesActa Neurologica Scandinavica, 1987
- Rating neurologic impairment in multiple sclerosisNeurology, 1983
- New diagnostic criteria for multiple sclerosis: Guidelines for research protocolsAnnals of Neurology, 1983
- Surface glycoproteins of resting and activated human T lymphocytesMolecular and Cellular Biochemistry, 1979
- Leukocyte surface origin of human alpha1-acid glycoprotein (orosomucoid).Journal of Experimental Medicine, 1978
- Synthesis of α1-acid glycoprotein by the isolated perfused rat liverArchives of Biochemistry and Biophysics, 1963